Diagnosing a pituitary adenoma typically involves two main steps: blood tests to check hormone levels and an MRI of the brain focused on the pituitary gland. In some cases, a single blood test showing a dramatically elevated hormone level is enough to point to the diagnosis. More often, though, the process requires a combination of lab work, imaging, and sometimes specialized follow-up tests to confirm the type and size of the tumor.
Blood Tests: The First Step
The diagnostic workup almost always starts with a panel of blood tests measuring the hormones your pituitary gland produces or regulates. Because the pituitary controls so many systems in your body, this panel is broad. Common tests check prolactin, IGF-1 (which reflects growth hormone activity), cortisol and ACTH (tied to stress response and metabolism), thyroid hormones (TSH and free T4), and sex hormones like testosterone or estradiol along with LH and FSH.
These tests serve two purposes. First, they can reveal whether the tumor is overproducing a specific hormone, which helps identify the tumor type. Second, they can show whether the tumor is suppressing normal pituitary function, causing hormone deficiencies that need treatment. A high hormone level can sometimes be enough on its own to diagnose a pituitary tumor. Low hormone levels, on the other hand, typically need to be followed up with imaging to find out why.
Prolactin Levels and What They Mean
Prolactin-producing tumors (prolactinomas) are the most common type of functioning pituitary adenoma, and their diagnosis relies heavily on a single blood draw. Normal prolactin levels run below about 20 micrograms per liter in men and 25 in women. The key diagnostic question is how high the number goes.
A prolactin level above 250 micrograms per liter in someone with a tumor larger than 1 cm is generally considered diagnostic for a prolactinoma, per European Endocrine Society guidelines. Levels above 500 are almost always prolactinomas. Smaller prolactinomas typically push prolactin into the 100 to 200 range. The tricky zone is below 100, where up to 25% of small prolactinomas fall but where other explanations, including medications and non-functioning tumors pressing on the pituitary stalk, can also cause mild elevations. When a large tumor shows only mildly elevated prolactin (under 100), it’s actually more suspicious for a non-functioning adenoma that’s simply compressing the stalk and disrupting normal prolactin regulation.
Testing for Growth Hormone Excess
If your doctor suspects acromegaly (excess growth hormone, often from a pituitary adenoma), the first test is a blood level of IGF-1, a protein the liver makes in response to growth hormone. IGF-1 is more useful than measuring growth hormone directly because growth hormone fluctuates throughout the day while IGF-1 stays relatively stable. An IGF-1 level that falls within the normal range for your age and sex effectively rules out acromegaly.
When IGF-1 comes back elevated or borderline, the next step is a confirmatory test called an oral glucose tolerance test. You drink a sugary solution containing 75 grams of glucose, then your growth hormone is measured at timed intervals. In a healthy person, the sugar load suppresses growth hormone below 1 microgram per liter (or below 0.4 with newer, more sensitive assays). If growth hormone fails to drop below that threshold, the diagnosis of acromegaly is confirmed.
Screening for Cushing’s Disease
When a pituitary adenoma produces too much ACTH, it drives the adrenal glands to overproduce cortisol, causing Cushing’s disease. Diagnosing this is notoriously difficult because cortisol levels naturally vary throughout the day and spike with stress or illness.
One of the most common initial screening tests is the overnight dexamethasone suppression test. You take a small dose of a synthetic steroid (1 mg) at bedtime, then have your blood drawn the next morning. In a healthy person, the medication signals the pituitary to stop producing ACTH, and morning cortisol drops below 1.8 micrograms per deciliter. If cortisol stays above that threshold, it suggests the normal feedback loop isn’t working, which raises suspicion for Cushing’s. This test is designed for high sensitivity at this screening stage, meaning it catches the vast majority of true cases but can sometimes flag people who don’t actually have the condition. Positive results lead to additional confirmatory testing before a diagnosis is made.
MRI: Seeing the Tumor
The standard imaging tool for pituitary adenomas is a dedicated MRI of the pituitary region, not a routine brain MRI. The protocol uses thin slices focused on the small bony compartment (the sella) where the pituitary sits. The standard sequences include images taken before and after injection of a gadolinium-based contrast dye, viewed from both the front (coronal) and the side (sagittal), along with a specific sequence that helps distinguish different tissue types.
Contrast injection is particularly important for finding small tumors. Normal pituitary tissue enhances brightly with gadolinium, while most adenomas enhance more slowly. This difference in timing creates a visible contrast that makes even tiny tumors stand out. For most cases, the standard protocol is sufficient. In more complex situations, advanced techniques like diffusion-weighted imaging or high-resolution 3D sequences can provide additional detail.
Size Classification
Pituitary adenomas are classified by size. Tumors smaller than 10 mm (1 cm) are called microadenomas, while those 10 mm or larger are macroadenomas. This distinction matters because macroadenomas are more likely to compress surrounding structures, including the optic nerves, and are more likely to need treatment based on size alone regardless of whether they produce excess hormones. Some researchers have argued that a more clinically meaningful cutoff would be 20 or 30 mm, since many macroadenomas just over 1 cm behave more like smaller tumors in terms of treatment decisions.
Visual Field Testing
Larger pituitary adenomas can grow upward and press on the optic chiasm, the crossing point of the optic nerves just above the pituitary. This compression causes characteristic patterns of vision loss, most commonly affecting your peripheral vision on both sides (the outer “temple” fields of each eye). Your doctor checks for this with a formal visual field test, typically automated perimetry, where you look at a screen and press a button when you see small flashing lights in different parts of your visual field.
The textbook pattern of pure loss of both outer visual fields is actually uncommon in practice. A study of 119 patients with pituitary macroadenomas found that the most frequent finding (about 43% of cases) was a mix of outer-field loss combined with other visual deficits, likely because larger tumors compress more than just the chiasm. This means any new or unexplained pattern of vision loss, not just the classic textbook pattern, warrants investigation in the context of a known or suspected pituitary mass.
Incidental Discoveries
Many pituitary adenomas are found by accident on brain MRIs done for unrelated reasons, like headaches or head injuries. These are called incidentalomas, and they still require a proper workup. Current consensus guidelines from the Pituitary Society recommend that all patients with an incidentally discovered pituitary mass get a full hormonal evaluation and, ideally, consultation with an endocrinologist.
Even if the tumor appears non-functioning, repeat hormone testing is recommended at one to two years because new hormone deficiencies can develop over time, sometimes without the tumor visibly growing. For very small incidentalomas under 5 mm that remain stable on follow-up MRIs done every two to three years, the need for continued imaging can be reassessed. Macroadenomas found incidentally generally warrant closer surveillance and may need a visual field test to check for optic nerve compression.
What Can Mimic a Pituitary Adenoma
Not every mass found near the pituitary turns out to be an adenoma. The region where the pituitary sits is a crossroads of sorts, and several other types of growths and cysts can appear there. These include fluid-filled cysts (Rathke cleft cysts), other tumor types like craniopharyngiomas, and sometimes inflammatory conditions. Many of these can mimic the hormonal and imaging features of a pituitary adenoma, which is why the combination of blood work, imaging characteristics, and clinical symptoms matters. A mass that doesn’t fit the typical pattern on MRI or produces an unusual hormone profile may require additional specialized testing or sometimes a tissue biopsy during surgery to reach a definitive diagnosis.